Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 2/2014

01-02-2014 | Letter to the Editors

Comment on: Oxidative stress in erythrocytes from patients with rheumatoid arthritis

Authors: Turgay Ulas, Mehmet Sinan Dal, Mehmet Emin Demir, Hakan Buyukhatipoglu

Published in: Rheumatology International | Issue 2/2014

Login to get access

Excerpt

Sir, …
Literature
1.
2.
Buyukhatipoglu H, Sezen Y, Yildiz A, Bas M, Kirhan I, Ulas T, Turan MN, Taskin A, Aksoy N (2010) N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions. Pol Arch Med Wewn 120:383–389PubMed
Metadata
Title
Comment on: Oxidative stress in erythrocytes from patients with rheumatoid arthritis
Authors
Turgay Ulas
Mehmet Sinan Dal
Mehmet Emin Demir
Hakan Buyukhatipoglu
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2636-5

Other articles of this Issue 2/2014

Rheumatology International 2/2014 Go to the issue

Original Article

A possible genetic association with chronic fatigue in primary Sjögren’s syndrome: a candidate gene study

Letter to the Editor

Mevalonate kinase deficiency nomenclature

Original Article

Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy

Letter to the Editor

Comment on Song et al.: associations between the major histocompatibility complex class I chain-related gene A transmembrane (MICA-TM) polymorphism and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis

Original Article

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

Letter to the Editor

DPP4 inhibitor-induced polyarthritis: a report of three cases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits